Table 2 The percentages of relative cytokine gene expression in PBMCs after treatments at the concentration of 50 µg/mL for 48 h, normalized by β-actin.

DMSO

100.00 ± 0.00^a

100.00 ± 0.00^a

100.00 ± 0.00^a

100.00 ± 0.00^a

100.00 ± 0.00^a

100.00 ± 0.00^a

B. cristata

430.72 ± 4.02^b

224.44 ± 4.64^b

565.70 ± 3.65^b

510.91 ± 4.52^b

428.82 ± 1.64^b

410.73 ± 1.17^b

B. siamensis

865.10 ± 4.18^b

370.40 ± 9.89^b

571.55 ± 5.30^b

419.50 ± 2.43^b

759.80 ± 5.83^b

722.35 ± 5.57^b

B. strigosa

739.66 ± 7.51^b

497.34 ± 2.85^b

586.51 ± 3.38^b

118.39 ± 8.53^a

104.33 ± 5.39^a

92.791 ± 0.43^a

Barlerin

182.87 ± 2.78^b

133.12 ± 5.72^b

198.94 ± 6.88^b

190.68 ± 6.49^b

240.84 ± 7.26^b

346.69 ± 6.34^b

Verbascoside

353.40 ± 8.59^b

242.98 ± 2.50^b

347.74 ± 6.48^b

253.94 ± 8.70^b

278.92 ± 0.94^b

227.96 ± 6.54^b